← FDA Drug Approvals (Drugs@FDA)
APREMILAST
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHILPA · Approved 2023-04-07
Drug application
- FDA Application #
ANDA211774- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- APREMILAST
- Generic name
- Apremilast
- Active ingredients
- APREMILAST
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SHILPA
- First approval
- 2023-04-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown